Skip to content

The Prevention of lower extremity deep Venous thrombosis post gynecological surgery: A prospective, randomized and cases controlled study

The Prevention of lower extremity deep Venous thrombosis post gynecological surgery: A prospective, randomized and cases controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-PRC-10000935
Enrollment
Unknown
Registered
2010-06-23
Start date
2010-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lower extremity deep vein thrombosis (DVT) post gynecological pelvic surgeries

Interventions

Prevention and treatment group:graduated compression stockings (GCS) + intermittent pneumatic pressure pump (IPC)
Prevention and treatment group:Given graduated compression stockings (GCS) + Fragmin
Prevention and treatment group:graduated compression stockings (GCS

Sponsors

Department of Gynecology and Obstetrics, Beijing Chaoyang Hospital of Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 85 Years

Inclusion criteria

Inclusion criteria: patients who have the high risk factors (Age >=60 years,cancer, history of DVT or PE,With thrombotic tendency) to receiving gynecological pelvic surgeries

Exclusion criteria

Exclusion criteria: 1. Thrombophlebitis or pulmonary embolism; 2. Acute deep venous thrombosis; 3. Platelet <100*10^9/L, or blood coagulation disorder; 4. Bleeding tendency, within the past six months, intracranial hemorrhage or gastrointestinal bleeding; 5. Congestive heart failure, pulmonary edema, or leg edema; 6. Combined blood system diseases, serious liver and kidney dysfunction, heparin allergic patients: heparin contraindicated, not for the prevention study; 7. Leg severely abnormal conditions (such as dermatitis, gangrene, or the recent acceptance of skin transplant), severe atherosclerosis of lower extremity vascular or other ischemic vascular disease or severe leg deformities.

Design outcomes

Primary

MeasureTime frame
CT pulmonary angiography;Color Doppler ultrasound (CDFI) diagnosis;

Secondary

MeasureTime frame
PT, APTT, D-Dimer, AT-III, PAI, tPA, blood routine tests;

Countries

China

Contacts

Public ContactZhenyu Zhang
zhenyuz@yahoo.com+86 13801237287

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026